Ignite Creation Date:
2024-05-05 @ 4:39 PM
Last Modification Date:
2024-10-26 @ 9:22 AM
Study NCT ID:
NCT00284752
Status:
COMPLETED
Last Update Posted:
2012-10-01
First Post:
2006-01-30
Brief Title:
Phase II Trial of Abraxane in Front Line Therapy of Hormone Refractory Metastatic Prostate Cancer
Sponsor:
Kaiser Permanente
Organization:
Kaiser Permanente
Organization Data
Organization:
Kaiser Permanente
Class:
OTHER
Study ID:
TK001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Kaiser Permanente
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Celgene Corporation | INDUSTRY |